An unexpected role for the ketogenic diet in triggering tumor metastasis by modulating BACH1-mediated transcription
Open Access
- 7 June 2024
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (23) , eadm9481
Abstract
We have found that the ketogenic (Keto) diet is able to, unexpectedly, promote the metastatic potential of cancer cells in complementary mouse models. Notably, the Keto diet–induced tumor metastasis is dependent on BTB domain and CNC homolog 1 (BACH1) and its up-regulation of pro-metastatic targets, including cell migration–inducing hyaluronidase 1, in response to the Keto diet. By contrast, upon genetic knockout or pharmacological inhibition of endogenous BACH1, the Keto diet–mediated activation of those targets is largely diminished, and the effects on tumor metastasis are completely abolished. Mechanistically, upon administration of the Keto diet, the levels of activating transcription factor 4 (ATF4) are markedly induced. Through direct interaction with BACH1, ATF4 is recruited to those pro-metastatic target promoters and enhances BACH1-mediated transcriptional activation. Together, these data implicate a distinct transcription regulatory program of BACH1 for tumor metastasis induced by the Keto diet. Our study also raises a potential health risk of the Keto diet in human patients with cancer.Keywords
This publication has 65 references indexed in Scilit:
- Mechanisms of Cancer CachexiaPhysiological Reviews, 2009
- The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trialThe Lancet Neurology, 2008
- Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglyceridesBMC Cancer, 2008
- Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensorBlood, 2007
- Coping with stress: eIF2 kinases and translational controlBiochemical Society Transactions, 2006
- Systemic inflammation, cachexia and prognosis in patients with cancerCurrent Opinion in Clinical Nutrition and Metabolic Care, 2005
- Hemoprotein Bach1 regulates enhancer availability of heme oxygenase‐1 geneThe EMBO Journal, 2002
- Cystatin-like metastasis-associated protein mRNA expression in human colorectal cancer is associated with both liver metastasis and patient survival.2002
- Identification of Activating Transcription Factor 4 (ATF4) as an Nrf2-interacting ProteinJournal of Biological Chemistry, 2001
- CMAP: a novel cystatin-like gene involved in liver metastasis.1999